A Phase I Dose Escalation Study of NMS-03597812, a PERK inhibitor, in Adult Patients with Relapsed or Refractory Multiple Myeloma
NOT ENROLLING
Trial ID:
NCT05027594 Protocol # :
21-147
Phase
I
Disease Sites
Multiple Myeloma
Principal Investigator
Richardson, Paul, G
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #21-147
21-147